Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Objectives. We aimed at evaluating both the efficacy and safety of TJ-54 (Yokukansan) in patients with treatment-resistant schizophrenia. This randomized, multicenter, double-blind, placebo-controlled study was conducted. Methods. One hundred and twenty antipsychotic-treated inpatients were included...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyaoka, Tsuyoshi, Furuya, Motohide, Horiguchi, Jun, Wake, Rei, Hashioka, Sadayuki, Thoyama, Masaya, Murotani, Kenta, Mori, Norio, Minabe, Yoshio, Iyo, Masaomi, Ueno, Shuichi, Ezoe, Sachiko, Hoshino, Syuzo, Seno, Haruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411464/
https://www.ncbi.nlm.nih.gov/pubmed/25954314
http://dx.doi.org/10.1155/2015/201592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411464/
https://www.ncbi.nlm.nih.gov/pubmed/25954314
http://dx.doi.org/10.1155/2015/201592

Ejemplares similares